Lumexa Imaging Holdings, Inc. Debt Issuance Costs, Gross
Lumexa Imaging Holdings, Inc. (LMRI) had Debt Issuance Costs, Gross of $19.30 million as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt
us-gaap:DeferredFinanceCostsGross · last filed 2026-08-13
- 2025-12-31: Debt Issuance Costs, Gross $19.30M.
| Period end | Debt Issuance Costs, Gross |
|---|---|
| 2025-12-31 | $19.30M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |